{
    "paper_id": "ec1cf3827621ff2cdf454e7cf7e63b7a265f3d68",
    "metadata": {
        "title": "ARTICLE IN PRESS +Model",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": ". In the current situation of health crisis, they must be offered rapid treatment, but adapted to the epidemiological context.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Considering that the Covid-19 epidemic should not be a loss of opportunity for cancer patients, the French National Academy of Medicine recommends:",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u2022 that the possibilities of recourse to care are safeguarded:",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u2022 uncertainties about the duration of the epidemic should not postpone the initiation of curative cancer treatment indefinitely and thus add cancer mortality to Covid-19 mortality, \u2022 patients with localized cancers or cancers considered curable should be treated as soon as possible, \u2022 cancer patients requiring treatment should continue to be cared for in dedicated services, including in health care facilities for Covid-19 patients, \u2022 the practice of tumour biopsies must be maintained before any therapeutic decision is taken in the event of suspicion of malignant disease, \u2022 when, for practical reasons, surgery cannot be performed, the patient should be referred to another team that is more available, DOI of original article:https://doi.org/10.1016/j.banm.2020. 05.057. \u0b1d Press release from the National Academy of Medicine, April 12, 2020..",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u2022 when the chances of curability are uncertain, but there is hope of prolonged survival or even cure, the curative treatment strategy must be undertaken without delay, \u2022 therapeutic decisions continue to be discussed in a multidisciplinary consultation meeting (RCP).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Q1"
        },
        {
            "text": "\u2022 to adapt the management of certain patients to the epidemic context:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Q1"
        },
        {
            "text": "\u2022 the occurrence of Covid-19 in patients with cancer must be the subject of scientific research for an adapted therapy, \u2022 Multidisciplinary consultation meetings (RCP) must be based on the guidelines of learned societies, cancer networks or French Unicancer, to discuss the management of complex cases related to Covid-19, \u2022 oral treatments (targeted therapies, hormone therapy, chemotherapy, cytotoxic treatments. . .) are to be preferred during this period if they give equivalent results to the usual cytotoxic chemotherapies administered intravenously, \u2022 non-surgical locoregional approaches should be discussed in RCP in the face of pauci-metastatic disease, \u2022 targeted therapies/immunotherapies/maintenance treatments that have proven effective in a given patient should not be interrupted; spacing of inter-cures or flexibility of treatment regimens can be proposed and discussed in RCP, \u2022 follow-up by teleconsultation with the treating physician should be provided, whenever possible, to limit movement during the confinement period. It is necessary to maintain contact of cancer patients with medical and paramedical staff and health care facilities so as not to add a feeling of abandonment to the stress of confinement in an already complex and anxiety-provoking care pathway, \u2022 admission to palliative care services must be carefully considered, assessing the risks associated with displacement and exposure to Sars CoV-2 on the one hand, and the expected benefit of hospitalization on the other.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Q1"
        },
        {
            "text": "The author declares that he has no competing interest.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Disclosure of interest"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lia",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Oncol",
            "volume": "21",
            "issn": "20",
            "pages": "30096--30102",
            "other_ids": {
                "DOI": [
                    "10.1016/S1470-2045"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Clinical characteristics of COVID-19-infected cancer patients: a retro-Q5 spective case study in three hospitals within Wuhan, China",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ann Oncol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "file:/localhost/opt/grobid/grobid-home/tmp/dx.doi.org/10.1016/S1470-2045(20)30096-6"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "ScienceDirect www.sciencedirect.com CORONAVIRUS : AVIS DE L'ACAD\u00c9MIE NATIONALE DE M\u00c9DECINE Oncology and COVID-19 \u0b1d Cancer patients are at increased risk of developing a severe, Q3 even lethal, form of Sars CoV-2 infection",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}